Cite

    Vivek Shinde et al.. “Comparison of the safety and immunogenicity of a novel Matrix-M-adjuvanted nanoparticle influenza vaccine with a quadrivalent seasonal influenza vaccine in older adults: a phase 3 randomised controlled trial.” Lancet infectious diseases, vol. 22, no. 1, 2022, pp. 73–84. http://access.bl.uk/ark:/81055/vdc_100148069308.0x000007